About this policy
The comment period for the MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma DL39389 Local Coverage Determination (LCD) began on 10/06/2022 and ended on 11/19/2022. The notice period for L39389 begins on 06/22/2023 and will become effective on 08/06/2023. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.